Genesis Labs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 22-12-2024
- Paid Up Capital ₹ 1.57 M
as on 22-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.88 Cr
as on 22-12-2024
About Genesis Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.57 M.
The company has closed loans amounting to ₹1.88 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Naresh Sitaram, Sangeeta Arunkumar, and Karan Mengar serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PLC155922
- Company No.
155922
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Genesis Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Sitaram  | Director | 06-Sep-2005 | Current |
| Sangeeta Arunkumar | Director | 06-Sep-2005 | Current |
| Karan Mengar | Director | 17-Mar-2023 | Current |
Financial Performance of Genesis Labs.
Genesis Labs Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Genesis Labs?
In 2017, Genesis Labs had a promoter holding of 95.04% and a public holding of 4.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sakarwadi Trading Company Private LimitedActive 51 years 9 monthsNaresh Sitaram and Karan Mengar are mutual person
- Somaiya Chemical Industries Private LimitedActive 64 years 4 months
Naresh Sitaram is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 27 Sep 2006 | ₹9.40 M | Satisfied |
Bank Of Maharashtra Creation Date: 26 Sep 2006 | ₹9.40 M | Satisfied |
How Many Employees Work at Genesis Labs?
Unlock and access historical data on people associated with Genesis Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genesis Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesis Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
